Introduction Semaglutide Is rapidly emerging as a revolutionary medication in the treatment of type 2 diabetes, obesity, and related cardiovascular conditions. Initially designed to improve blood sugar control in people with type 2 diabetes, Semaglutide is a part of the GLP-1 (glucagon-like peptide-1) receptor agonists class of drugs. This class https://messiahycadi.dsiblogger.com/64390736/semaglutide-a-breakthrough-in-managing-diabetes-weight-and-heart-health